Skip to content

Acta Psychiatrica Scandinavica

ISSN 0001-690X

24 papers in the library · 1,728 citations · publishing 1975-2026

Papers

Sort Most recent Most cited

Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses

Acta Psychiatrica Scandinavica April 8, 2026 A. Mustonen, S. Niemelä, Alexander Denissoff et al.

Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in comparison with FEP without substance use disorder (SUD).

Effects of Intravenous Ketamine on Posttraumatic Stress Disorder ( PTSD ): A Systematic Review

Acta Psychiatrica Scandinavica December 1, 2025 Liyang Yin, A. Imamog ̄lu, Gia Han Le et al. 3 citations

ABSTRACT Introduction Posttraumatic stress disorder (PTSD) is a mental disorder resulting from exposure to traumatic events. Evidence suggests that ketamine may be efficacious in treating PTSD, however, ketamine's mechanisms in treating PTSD remain unclear. Herein, this review aims to evaluate the clinical outcomes of ketamine treatment in persons with PTSD and investigate the possible...

The Influence of Childhood Trauma on the Real‐World Effectiveness of Ketamine in Adults With Treatment‐Resistant Depression

Acta Psychiatrica Scandinavica April 16, 2025 Danica E. Johnson, Nelson B. Rodrigues, Rodrigo B. Mansur et al.

Childhood trauma is a well‐established risk factor for major depressive disorder (MDD) and is often associated with attenuated response to conventional antidepressant therapies. Ketamine has emerged as an effective treatment for treatment‐resistant depression (TRD), but the impact of childhood trauma on its effectiveness remains unclear. Herein, we aimed to determine whether childhood trauma...

Randomized Controlled Trials of Psilocybin‐Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta‐Analysis

Acta Psychiatrica Scandinavica December 3, 2024 Vikas Menon, Parthasarathy Ramamurthy, Sandesh Venu et al. 15 citations

ABSTRACT Introduction There is growing interest in the use of psychedelic‐assisted therapy (PAT) for major depressive disorder (MDD), including treatment‐resistant depression. We used randomized controlled trial (RCT) data to compare summary estimates of change in depression ratings with PAT versus comparator treatments in MDD. We also compared response and remission rates, and adverse effects....

Exploring the potential of a bridge therapy: Synergistic approach integrating intravenous ketamine and intranasal esketamine for treatment‐resistant depression

Acta Psychiatrica Scandinavica September 8, 2023 Giacomo D’andrea, Mauro Pettorruso, T. Rhee et al. 8 citations

Depressive disorders represent a significant economic and health burden globally. This is particularly evident in treatment-resistant depression (TRD), commonly defined as the absence of a satisfactory response to at least two different antidepressant trials (as defined by the U.S. Food and Drug Administration/FDA and European Medicine Agencies/EMA). The foregoing TRD cases frequently manifest...

Does a history of cannabis use influence onset and course of schizophrenia?

Acta Psychiatrica Scandinavica April 24, 2023 Peter Alle­beck, Tove Gunnarsson, Andreas Lundin et al. 5 citations

INTRODUCTION: While evidence strongly supports a causal effect of cannabis on psychosis, it is less clear whether the symptom pattern, clinical course, and outcomes differ in cases of schizophrenia with and without a background of cannabis use. METHODS: Analysis of medical records from a longitudinal follow-up of Swedish conscripts with data on cannabis use in adolescence and subsequent...

Nitrous oxide for the treatment of psychiatric disorders: A systematic review of the clinical trial landscape.

Acta Psychiatrica Scandinavica August 1, 2022 Helen Liu, Jaimie Kerzner, Ilya Demchenko et al.

To systematically review published research studies and ongoing clinical trials investigating nitrous oxide (N2 O) in psychiatric disorders, providing an up-to-date snapshot of the clinical research landscape. A comprehensive literature search was conducted for studies published until June 2021 using the OVID databases (MEDLINE, Embase, APA PsycInfo) and the clinical trial registries...

Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies

Acta Psychiatrica Scandinavica October 30, 2020 Kristoffer Andreas Aamodt Andersen, Robin Carhart-Harris, David Nutt et al. 352 citations

Abstract Objective To conduct a systematic review of modern‐era (post‐millennium) clinical studies assessing the therapeutic effects of serotonergic psychedelics drugs for mental health conditions. Although the main focus was on efficacy and safety, study characteristics, duration of antidepressants effects across studies, and the role of the subjective drug experiences were also reviewed and...

Adverse events in meditation practices and meditation‐based therapies: a systematic review

Acta Psychiatrica Scandinavica August 21, 2020 Miguel Farias, E. Maraldi, K. C. Wallenkampf et al.

Meditation techniques are widely used as therapy and wellbeing practices, but there are growing concerns about its potential for harm. The aim of the present study is to systematically review meditation adverse events (MAEs), investigating its major clinical categories and its prevalence.

The effects of ketamine on typical and atypical depressive symptoms

Acta Psychiatrica Scandinavica July 17, 2020 Lawrence T. Park, David A. Luckenbaugh, Steven Pennybaker et al. 23 citations

OBJECTIVE: Ketamine's effects on different dimensions of depressive symptomatology, including typical/melancholic and atypical depression, remain largely unknown. This study examined the effects of a single intravenous dose of ketamine on general depressive symptoms (measured using the Montgomery-Asberg Depression Rating Scale (MADRS), typical/melancholic symptoms (measured using the MADRS5),...

Stopping cannabis use benefits outcome in psychosis: findings from 10‐year follow‐up study in the PAFIP‐cohort

Acta Psychiatrica Scandinavica August 5, 2019 E. Setién-Suero, Karl Neergaard, V. Ortiz-García de la Foz et al.

To examine the long‐term (up to 10 years) patterns related to cannabis use in a sample of patients with first episode of psychosis (FEP) and the effect that consumption might have on clinical, functioning, and neurocognition at long‐term.

Everything old is new again: are psychedelic medicines poised to take mental health by storm?

Acta Psychiatrica Scandinavica October 26, 2018 Charles L. Raison

Three years ago, when I accepted a position as Director of Clinical and Translational Research at Usona Institute, a non-profit medical research organization pursuing a new drug indication for the psychedelic medicine psilocybin, many of my colleagues in mental health research looked at me like I had two heads. A year later, many of these same colleagues were beginning to ask me how they could...

Effects of psilocybin therapy on personality structure

Acta Psychiatrica Scandinavica June 19, 2018 David Erritzøe, Leor Roseman, Matthew M. Nour et al. 268 citations

Objective To explore whether psilocybin with psychological support modulates personality parameters in patients suffering from treatment‐resistant depression (TRD). Method Twenty patients with moderate or severe, unipolar, TRD received oral psilocybin (10 and 25 mg, one week apart) in a supportive setting. Personality was assessed at baseline and at 3‐month follow‐up using the Revised NEO...

Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations

Acta Psychiatrica Scandinavica September 21, 2017 Felix Müller, Claudia Lenz, Patrick C. Dolder et al. 149 citations

Objective It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system. Method 100 μg LSD was...

Mindfulness‐Based Stress Reduction and Mindfulness‐Based Cognitive Therapy – a systematic review of randomized controlled trials

Acta Psychiatrica Scandinavica April 28, 2011 Lone Overby Fjorback, Mikkel Arendt, Eva Ørnbøl et al. 810 citations

UNLABELLED: Fjorback LO, Arendt M, Ørnbøl E, Fink P, Walach H. Mindfulness-Based Stress Reduction and Mindfulness-Based Cognitive Therapy - a systematic review of randomized controlled trials. OBJECTIVE: To systematically review the evidence for MBSR and MBCT. METHOD: Systematic searches of Medline, PsycInfo and Embase were performed in October 2010. MBSR, MBCT and Mindfulness Meditation were...

Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia.

Acta Psychiatrica Scandinavica March 1, 2002 L A Núñez, M Gurpegui

The existence of cannabis-induced psychosis (CP) remains controversial, partly because of methodological problems. We hypothesize that acute schizophrenia (AS) and CP can have distinct demographic, premorbid and clinical features. We compared 26 patients with CP to 35 with AS, after their cannabis-consumption status was confirmed by repeated urine screens. Patients with CP were assessed after...

Spirit possession and healing among Chinese psychiatric patients.

Acta Psychiatrica Scandinavica December 1, 1993 E H Kua, P H Chew, S M Ko 48 citations

This is a study of the illness behaviour of 100 Chinese psychiatric patients referred consecutively to the psychiatric unit of a general hospital in Singapore. More women than men felt that their illness was due to spirit possession; but belief in possession was not related to educational status. Thirty-six patients or their relatives had consulted a traditional healer before going to the...

A retrospective study of symptom patterns of cannabis-induced psychosis.

Acta Psychiatrica Scandinavica February 1, 1991 A G Imade, J C Ebie

The aim of this study was to find out whether there are any similarities between cannabis psychosis on the one hand and schizophrenia and mania on the other, and to delineate any consistency in the pattern of clinical symptoms of cannabis psychosis. Relevant data were collected from patient's case-notes depicting biographical information and the frequencies of mental symptoms. Age and duration...

Khat‐induced hypnagogic hallucinations

Acta Psychiatrica Scandinavica October 1, 1988 M. Granek, A. Shalev, A. M. Weingarten

ABSTRACTKhat is a plant whose leaves are chewed for their stimulating effect. This effect is attributed to cathinone, an alkaloid identical to dextroamphetamine. Khat chewing is widespread among eastern African and Yemenite populations and is believed to be innocuous. Our experience shows, however, that a substantial number of chronic khat chewers experience persistent hypnagogic hallucinations...

Cannabis psychoses in south Sweden.

Acta Psychiatrica Scandinavica October 1, 1982 A Pålsson, S O Thulin, K Tunving

Eleven patients with a psychosis in connection with cannabis abuse admitted to two mental hospitals during 1 year were examined. Patients with a pre-existent psychosis or a mixed abuse were excluded. The patients were divided into three groups: acute, subacute and chronic. The features of the disease were essentially similar in all patients, with a mixture of affective and schizophrenia-like...

Hypnagogic and hypnopompic hallucinations during amitriptyline treatment.

Acta Psychiatrica Scandinavica October 1, 1980 R Hemmingsen, O J Rafaelsen

Four cases of hypnagogic or hypnopompic visual hallucinations in patients during amitriptyline treatment are reported. The hallucinations were clearly delineated, projected to the outer objective space and were for a short time experienced as real. The patients rapidly realized the unreality of the "sights", probably because they regained the full criticism and coherent thinking of an...

LSD treatment in a severe case of compulsive neurosis

Acta Psychiatrica Scandinavica February 1, 1977 E. Brandrup, T Vanggaard 47 citations

A detailed account is given of the course and outcome of the treatment with LSD of an incapacitating compulsive‐neurotic condition in a 30‐year‐old male. The treatment took place over 1 1/2 years from the autumn of 1962, and the patient, who has been followed since then, is completely cured symptomatically. In addition, a fortunate change in his general personality has taken place. The events...

The concepts: Disturbed state of consciousness and psychosis.

Acta Psychiatrica Scandinavica February 1, 1975 A Aggernaes

A theoretical analysis is made of the two concepts: "disturbed state of consciousness" (DSC) and "psychosis", and these concepts are defined in ways which are consistent with actual clinical psychiatric work on the Continent. Concerning DSC's two points are emphasized: Whether we, as psychiatrists, are conscious of it or not--one of our premisses for classifying a state as a pathological DSC is...